Top: schematics showing location and orientation of immunostaining data in in embryonic day (E) 8.75 (Theiler stage [TS]13) and E9.0 (TS14) embryos. (A) Confocal sections of wholemount …
(A) Differentiation/tetracycline (Tet) treatment scheme. (B) Immunofluorescence analysis of the expression of TBXT in shRNA hEScell-derived NMPs in the presence and absence of Tet. Scale bar = 100 …
(A) Immunofluorescence analysis of the expression of TBXT in control B2M shRNA hESC-derived NMPs in the presence and absence of Tet. Scale bar = 100 μm. (B) qPCR expression analysis of indicated HOX …
(A) Differentiation/tetracycline (Tet) treatment scheme. (B) qPCR expression analysis of indicated HOX genes in control vs Tet-treated NMP-derived trunk NC cells. Error bars represent SD (n=4–6). *p<…
(A) Representative flow cytometry (FACS) plots showing the presence of SOX1-positive cells in trunk NC cultures generated from NMPs in the presence and absence of tetracycline (Tet) following …
(A) Differentiation/tetracycline (Tet) treatment scheme. The temporal Tet treatment regimens employed were: no Tet control (− −); Tet treatment between days 3 and 7 (− +); Tet treatment between days …
(A) Scheme of treatments during the differentiation of human pluripotent stem cells (hPSCs) toward NMPs. (B) qPCR expression analysis of representative WNT-FGF targets in NMP cultures treated with …
(A) Immunofluorescence analysis of the expression of HOXC9, SOX1, and SOX10 in trunk NC cultures treated with the indicated combinations of WNT-BMP agonists/antagonists. Scale bar = 100 µm. (B) …
(A) Fluorescence analysis of R26-WntVis mouse embryos at embryonic day (E) 8.75 (Theiler stage [TS]13) and E9.0 (TS14) demonstrating EGFP reporter responsiveness to WNT signalling. (B) Sagittal …
(A, D) Differentiation/treatment schemes associated with different time windows of TBXT knockdown during spinal cord differentiation from NMPs. (B–C, E–F) qPCR expression analysis of indicated HOX …
(A) Scheme of treatments during the differentiation of hPSC-derived NMPs toward early spinal cord progenitors. (B–C) qPCR expression analysis of indicated HOX genes (B) and representative NMP/early …
Immunofluorescence analysis of CDX2 and HOXC9 protein expression in NMP-derived early pre-neural spinal cord progenitor cultures treated with the indicated combinations of WNT-FGF …
(A) Representative transcription factor-binding motifs enriched in TBXT binding sites. (B) Graph showing the percentages of differentially expressed genes (padj<0.05, log2FC>|1|) following TBXT …
(A) Average density plot of tag distributions across peak regions corresponding to the neuromesodermal progenitor (NMP), human embryonic stem cells (hES), and input samples. (B) Genomic distribution …
Correspondence between TBXT binding (ChIP) in human pluripotent stem cell (hPSC)-derived NMPs and chromatin accessibility changes (ATAC-seq) in NMPs (D3) and NMP-derived early spinal cord (D7 SC) …
Significantly up- and downregulated transcripts in Tet-treated, TBXT-depleted hESC-derived NMPs.
List of GO terms and corresponding gene lists enriched in Tet-treated, TBXT depleted hESC-derived NMPs.
List of all genomic regions (Intervals) with peak p-value below the applied threshold bound by TBXT in hESC-derived NMPs and undifferentiated hESCs.
List of GO terms and corresponding gene lists associated with TBXT binding sites in hPSC-derived NMPs.
List of known HOMER database motifs enriched in TBXT binding sites in hESC-derived NMPs.
List of TBXT target genes which are differentially expressed following Tet treatment (padj<0.05 log2FC>|0.5|) and Gene Ontology Biological Processes enrichment analysis.
Genes are listed in relation to the genomic position (in relation to TSS) of TBXT binding within their proximity. Blue highlight denotes downregulation while red represents upregulation in expression.
List of ATAC-seq peaks associated with gain or loss of chromatin accessibility following TBXT depletion in hESC-derived NMPs.
Gene Ontology Biological Processes enrichment analysis, list of HOX genes as well as other genes (padj<0.05 log2FC>|1|) affected by TBXT depletion and are associated with changes in chromatin accessibility are also included.
List of transcription factor DNA binding motifs enriched in ATAC-seq sites associated with chromatin accessibility gain, chromatin accessibility loss or both.
ATAC-seq analysis of trunk NC cells generated from hPSCs via NMPs in the presence of Tet.
Includes: (i) Summary: Summary of detected peak numbers; (ii) all_peaks: List of all the peaks with P-value <0.05 (gained open, gained close, no change) with the relative annotations; (iii) Accessibility Loss padj <0.05: Significant Gained close peaks (pvalue adjusted (padj) <0.05); (iv) HOX genes: Peaks in HOX gene regions, yellow colour highlights the significant peaks (padj <0.05); (v) Enrichment-Accessibility Loss: Enrichment of Significant Gained close peaks (pvalue adjusted <0.05); (vi) Accessibility gain padj <0.05: Significant Gained close peaks (pvalue adjusted (padj) <0.05).
List of primers used.